Clearmind Medicine (NASDAQ:CMND) Trading Up 3.5% – Here’s What Happened

Clearmind Medicine Inc. (NASDAQ:CMND)’s share price was up 3.5% during mid-day trading on Thursday . The stock traded as high as $1.36 and last traded at $1.19. Approximately 312,450 shares changed hands during mid-day trading, a decline of 75% from the average daily volume of 1,238,406 shares. The stock had previously closed at $1.15.

Clearmind Medicine Stock Up 0.8 %

The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 0.01. The company’s fifty day moving average is $1.39 and its 200-day moving average is $1.37.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Clearmind Medicine stock. AdvisorShares Investments LLC lifted its stake in Clearmind Medicine Inc. (NASDAQ:CMND) by 14.2% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 128,641 shares of the company’s stock after buying an additional 15,948 shares during the quarter. AdvisorShares Investments LLC owned approximately 7.60% of Clearmind Medicine worth $214,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 96.05% of the company’s stock.

Clearmind Medicine Company Profile

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.